Invention Grant
- Patent Title: Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy
-
Application No.: US12854144Application Date: 2010-08-10
-
Publication No.: US09726669B2Publication Date: 2017-08-08
- Inventor: Phillip Kim , Xinjun Liu , Richard Kirkland , Tani Lee , Belen Ybarrondo , Sharat Singh
- Applicant: Phillip Kim , Xinjun Liu , Richard Kirkland , Tani Lee , Belen Ybarrondo , Sharat Singh
- Applicant Address: US TN Franklin
- Assignee: PIERIAN HOLDINGS, INC.
- Current Assignee: PIERIAN HOLDINGS, INC.
- Current Assignee Address: US TN Franklin
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/50
Abstract:
The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
Public/Granted literature
- US20110071042A1 BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY Public/Granted day:2011-03-24
Information query
IPC分类:
